Aquestive therapeutics reports second quarter 2022 financial results and provides business update

Warren, n.j., aug. 02, 2022 (globe newswire) -- aquestive therapeutics, inc. (nasdaq: aqst), a pharmaceutical company advancing medicines to solve patients' problems with current standards of care and provide transformative products to improve their lives, today reported financial results for the second quarter ended june 30, 2022 and provided an update on recent developments in its business.
AQST Ratings Summary
AQST Quant Ranking